Invitrolize
Founded 2022 · 7 employees on LinkedIn · 1 known investors
Find your way into Invitrolize
Sign up to see every warm intro you have to Invitrolize
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Invitrolize team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
A company developing in vitro testing methods to assess respiratory sensitization for regulatory compliance in chemical and pharmaceutical industries.
Investors · 1
Expon Capitallisted by Expon CapitalLuxembourg · $550K – $1.6M
How we know: Expon Capital's portfolio page · a partner's Signal profile · funding news · exponcapital.com · Not right? Tell us
Funding
SEC filings, press & company announcements- Undisclosed amountSEEDMay 2025 · 2 sourcesSource ↗
Source: company announcements and press reports — follow each round's link for the claim.
Frequently asked questions
- What does Invitrolize do?
- A company developing in vitro testing methods to assess respiratory sensitization for regulatory compliance in chemical and pharmaceutical industries.
- Who are Invitrolize's investors?
- Invitrolize's investors include Expon Capital.

